GOLGA4

Across TCGA pan-cancer cohorts, GOLGA4 mass-spec protein is linked to patient survival in 7 of 34 cancer types, making it a survival-associated GOLGA4 data layer compared with 24 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher GOLGA4 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated GOLGA4 expression acts as an unfavorable survival marker, although some lineages such as COAD and PDAC show a favorable association.

COAD, PDAC, and LUAD are the cancer types where GOLGA4 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	II,III,IV	1.000	0.882	.021	54	view →
PDAC	DFS	Median	All	0.851	0.676	.008	20	view →
LUAD	OS	Median	III,IV	0.861	0.384	.030	4	view →
CCRCC	DFS	Median	III,IV	0.455	0.694	.036	3	view →
GBM	DFS	Quartile	All	0.653	0.867	.023	2	view →
HNSC	DFS	Median	IV	0.889	0.407	.042	2	view →
LSCC	DFS	Median	All	0.644	0.896	.044	1	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

GOLGA4–COAD (DFS)

Open the COAD breakdown →